{"retracted":false,"update":{"timestamp":1372636800000,"doi":"10.1016/j.clim.2013.04.004","type":"err"},"doi":"10.1016/j.clim.2012.10.007","journal":"Clinical Immunology","publisher":"Elsevier BV","title":"Corrigendum to “Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer” [Clin. Immunol. 146 (2013) 26–33]"}
